Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Intervalo de ano de publicação
1.
Biochim Biophys Acta Mol Basis Dis ; 1863(9): 2192-2201, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28624490

RESUMO

Hydrogen sulfide (sulfide) accumulates at high levels in brain of patients with ethylmalonic encephalopathy (EE). In the present study, we evaluated whether sulfide could disturb energy and redox homeostasis, and induce mitochondrial permeability transition (mPT) pore opening in rat brain aiming to better clarify the neuropathophysiology of EE. Sulfide decreased the activities of citrate synthase and aconitase in rat cerebral cortex mitochondria, and of creatine kinase (CK) in rat cerebral cortex, striatum and hippocampus supernatants. Glutathione prevented sulfide-induced CK activity decrease in the cerebral cortex. Sulfide also diminished mitochondrial respiration in cerebral cortex homogenates, and dissipated mitochondrial membrane potential (ΔΨm) and induced swelling in the presence of calcium in brain mitochondria. Alterations in ΔΨm and swelling caused by sulfide were prevented by the combination of ADP and cyclosporine A, and by ruthenium red, indicating the involvement of mPT in these effects. Furthermore, sulfide increased the levels of malondialdehyde in cerebral cortex supernatants, which was prevented by resveratrol and attenuated by glutathione, and of thiol groups in a medium devoid of brain samples. Finally, we verified that sulfide did not alter cell viability and DCFH oxidation in cerebral cortex slices, primary cortical astrocyte cultures and SH-SY5Y cells. Our data provide evidence that bioenergetics disturbance and lipid peroxidation along with mPT pore opening are involved in the pathophysiology of brain damage observed in EE.


Assuntos
Encefalopatias Metabólicas Congênitas/metabolismo , Córtex Cerebral/metabolismo , Metabolismo Energético/efeitos dos fármacos , Sulfeto de Hidrogênio/efeitos adversos , Peroxidação de Lipídeos/efeitos dos fármacos , Proteínas de Transporte da Membrana Mitocondrial/metabolismo , Púrpura/metabolismo , Animais , Encefalopatias Metabólicas Congênitas/induzido quimicamente , Encefalopatias Metabólicas Congênitas/patologia , Linhagem Celular Tumoral , Córtex Cerebral/patologia , Sulfeto de Hidrogênio/farmacologia , Masculino , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Poro de Transição de Permeabilidade Mitocondrial , Púrpura/induzido quimicamente , Púrpura/patologia , Ratos , Ratos Wistar
2.
Metab Brain Dis ; 25(2): 145-54, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20431931

RESUMO

5-Oxoproline accumulates in glutathione synthetase deficiency, an autossomic recessive inherited disorder clinically characterized by hemolytic anemia, metabolic acidosis, and severe neurological symptoms whose mechanisms are poorly known. In the present study we investigated the effects of acute subcutaneous administration of 5-oxoproline to verify whether oxidative stress is elicited by this metabolite in vivo in cerebral cortex and cerebellum of 14-day-old rats. Our results showed that the acute administration of 5-oxoproline is able to promote both lipid and protein oxidation, to impair brain antioxidant defenses, to alter SH/SS ratio and to enhance hydrogen peroxide content, thus promoting oxidative stress in vivo, a mechanism that may be involved in the neuropathology of gluthatione synthetase deficiency.


Assuntos
Antioxidantes/metabolismo , Encefalopatias Metabólicas Congênitas/induzido quimicamente , Cerebelo/efeitos dos fármacos , Cérebro/efeitos dos fármacos , Peroxidação de Lipídeos/efeitos dos fármacos , Proteínas do Tecido Nervoso/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Ácido Pirrolidonocarboxílico/toxicidade , Fatores Etários , Animais , Antioxidantes/fisiologia , Encefalopatias Metabólicas Congênitas/metabolismo , Cerebelo/metabolismo , Cérebro/metabolismo , Modelos Animais de Doenças , Glutationa Sintase/deficiência , Peroxidação de Lipídeos/fisiologia , Proteínas do Tecido Nervoso/fisiologia , Estresse Oxidativo/fisiologia , Ácido Pirrolidonocarboxílico/metabolismo , Ratos , Ratos Wistar
3.
Metab Brain Dis ; 23(2): 189-98, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18437545

RESUMO

Guanidinoacetate methyltransferase deficiency (GAMT-deficiency) is an inborn error of metabolism biochemically characterized by accumulation of guanidinoacetate (GAA) and depletion of creatine; the pathogenesis of brain dysfunction in this disorder is not yet established. In the present study we investigated the effect of intrastriatal administration of GAA on acetylcholinesterase (AChE) activity and on memory acquisition, consolidation and retrieval of step-down inhibitory avoidance task in rat. Results showed that GAA significantly increased AChE activity in rat striatum 30 min (50%) and 3 h (25%), but not 6 h after drug administration. GAA impaired test session performance when applied 30 min before training or after training, and before testing sessions, i.e., impaired memory acquisition, consolidation and retrieval. When injected with a 6 hour interval, GAA affected only memory retrieval. Although the mechanisms of action of GAA on AChE activity and on memory are unclear, these findings suggest that the accumulation of GAA found in patients with GAMT-deficiency may be one of the mechanisms involved in neural dysfunction. Further studies are necessary to evaluate these mechanisms.


Assuntos
Acetilcolinesterase/metabolismo , Encefalopatias Metabólicas Congênitas/enzimologia , Corpo Estriado/enzimologia , Deficiências da Aprendizagem/enzimologia , Neurônios/enzimologia , Acetilcolina/metabolismo , Acetilcolinesterase/efeitos dos fármacos , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Aprendizagem da Esquiva/fisiologia , Encefalopatias Metabólicas Congênitas/induzido quimicamente , Encefalopatias Metabólicas Congênitas/fisiopatologia , Corpo Estriado/efeitos dos fármacos , Corpo Estriado/fisiopatologia , Modelos Animais de Doenças , Ativação Enzimática/efeitos dos fármacos , Ativação Enzimática/fisiologia , Glicina/análogos & derivados , Glicina/metabolismo , Glicina/toxicidade , Deficiências da Aprendizagem/induzido quimicamente , Deficiências da Aprendizagem/fisiopatologia , Neurônios/efeitos dos fármacos , Ratos , Retenção Psicológica/efeitos dos fármacos , Retenção Psicológica/fisiologia , Fatores de Tempo , Regulação para Cima/efeitos dos fármacos , Regulação para Cima/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA